Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

NCT05251766 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Chemotherapy Effect

Interventions

DRUG: Nab paclitaxel
DRUG: Docetaxel

Sponsor

Xuli Meng